|
Click on "PDF" for download slides only as pdf. Webcasts will be available late April. These webcasts combines presenter's video and audio with slides. Click on the presenter's name to view in all browsers, including Internet Explorer, Firefox and iPad/iMac. |
EAHP
Congress 2016 |
 |
Produced
by 
|
| Synergy | Interchangeability of biologicals in the EU – the science, practice, ethics and cost side? | Interchangeability of biosimilars – a financial, ethical, or scientific issue? Daan Crommelin The rules of engagement in Europe. Paul Declerck Introducing Biosimilars into the Hospital Formulary. Arnold Vulto Is our present system economically sustainable? Paul Cornes |
PDF |
| Synergy | Ready to use Drugs - a useful option for patient safety | Is there a need for them and how do we get them? Paul Le Brun How can we control the risks? Allison Beaney |
PDF |
| Workshop 1 | Antimicrobial optimisation: an interactive workshop for hospital pharmacists | ||
| Workshop 2 | The art of writing an abstract |
The art of writing an abstract. Gunar Stemer The art of writing an abstract. Thorsten Hoppe-Tichy |
PDF |
| Workshop 3 | Patient empowerment & communication | Patient and health professional. Stéphane Tessier |
PDF |
| Interactive Session 1 | Hospital Pharmacists taking the lead in Orphan Drugs: supply chain, partnerships and technologies | Hospital Pharmacists taking the lead in Orphan Drugs. Marc Dooms | |
| Interactive Session 2 | Implementing new technology: key factors to success | Tina Klok Wrønding |
|
| Interactive Session 3 | Developing and implementing clinical pathways | V. Fortineau |
|
Satellite
symposia (not ACPE accredited): The information related
to satellite symposia is provided to you by commercial companies, external
to EAHP. EAHP makes no representations or warranties of any kind, express
or implied, about the completeness, accuracy, reliability, suitability
or availability with respect to these presentations or the information,
products, services, or related graphics contained in the presentations
for any purpose. Any reliance you place on such information is therefore
strictly at your own risk. In no event will EAHP be liable for any loss
or damage including without limitation, indirect or consequential loss
or damage, or any loss or damage whatsoever arising from loss of data
or profits arising out of, or in connection with, the presentations.
|
|||
| Bayer | “NOACs in the hospital – what matters for optimal pharmaceutical care [part 1- Interprofessional Communication]” | Challenges
Challenges in Antithrombotic Care. Sotiris Antoniou The Role of Pharmacists in Multidisciplinary Teams. Rodney Hughes The role of pharmacists in multidisciplinary teams. Jannat Muen |
|
| BD | “The evolution of medication management - Medication safety from pharmacy to bedside” | How to achieve high levels of quality and safety for IV compounding and preparation workflow. Robert Terkola (to be published later) How improving the quality of medication management helps to reduce medication errors. Pascal Bonnabry Infusion medication safety at the bedside: experience in pediatric care. Silvia Manrique-Rodriguez |
PDF |
| Boehringer-Ingelheim | New innovations in anticoagulation care: a look behind the headlines | Evidence confirms clinical profile of dabigatran. Leonardo de Luca |
|
| European Biosimilars Group (EBG) | “The Facts about Biosimilars” | Intro. Maarten van Baelen |
PDF |
| Pfizer | “A Multidisciplinary approach to effective antimicrobial stewardship” |
Role of the pharmacist in antimicrobial stewardship programmes:
UK Hayley Wickens |
|
| Teva Pharmaceuticals Europe BV | The treatment journey: Supporting cancer patients every step of the way NO SLIDES AVAILABLE, JUST VIDEO | Optimal chemotherapy delivery. Rupert Bartsch Maximising quality of life. Lesley Fallowfield Managing Pain and palliation. Marcus Schlemmer |
|
